FDA Office of Regulatory Affairs Strategic Plan Development Survey

Throughout Fiscal Year 2020, FDA’s Office of Regulatory Affairs (ORA) will be developing a comprehensive, 10-year Strategic Plan. The Plan will identify ORA’s goals and objectives based on their core mission and priorities. It will be drafted by the Strategic Plan Development Workgroup, led by ORA’s Office of Strategic Planning and Operational Policy. Each ORA Office and Program has representatives on the Workgroup.

ORA is currently in the information gathering phase. This effort is intended as a collaborative activity in which all internal and external stakeholders are welcome to share ideas and feedback.

Take a quick, three-question survey to provide your input. Feedback can be submitted anonymously. The deadline to submit feedback is Friday, March 13.

Leave a Reply

Your email address will not be published. Required fields are marked *